Description

Tenet Healthcare Is Becoming An Ambulatory Care Powerhouse Through USPI!

Tenet Healthcare reported second quarter 2026 net operating revenues of $5.6 billion and consolidated adjusted EBITDA of $1.304 billion, achieving a 23.2% adjusted EBITDA margin that represented a 16.3% increase compared to the prior year. Adjusted diluted earnings per share rose 52% year-over-year to $6.12, supported by strong performance in its two main operating segments: United Surgical Partners International (USPI) and hospitals. USPI delivered adjusted EBITDA of $542 million in the quarter, representing 9% growth over Q2 2025 and achieving 25% of its full-year 2026 EBITDA guidance. Same-facility revenues increased 5%, driven by a focus on higher acuity procedures such as a 10% year-over-year growth in total joint replacements. The company emphasized a robust pipeline of partnerships aimed at expanding the ambulatory surgery center platform. In the hospital segment, adjusted EBITDA reached $762 million, a 22% increase from the prior year with an 18% margin. Inpatient adjusted admissions grew 2.